Loading…
Employees: 2,258
Size Hubei Hongyuan Pharmaceutical Technology (301246.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $639M, the 3267th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥15.89 on 6 Nov 2026.
Performance Over six months the shares fell 47.0%, against -24.5% for the median peer and -16.4% for the China market (cap-weighted) — 3rd lowest of 20 in its peer set.
Growth Revenue grew 45.2% over the last twelve months (peer median +10.8%); the operating margin is 12.3% (peer median 1.5%).
Valuation It trades at 1.5× enterprise value to sales against a peer median of 2.2× (7th cheapest of 20).
Capital Return on invested capital runs 0.2 points above its cost of capital (8.4% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥2.56B | CN¥1.94B | CN¥1.77B | CN¥2.05B | CN¥2.06B |
| Revenue growth | — | +9% | -14% | 0% | — |
| Gross profit | CN¥721M | CN¥333M | CN¥199M | CN¥247M | CN¥462M |
| EBITDA | n/a | CN¥323M | CN¥215M | CN¥217M | CN¥356M |
| Net income | CN¥304M | CN¥119M | CN¥51.5M | CN¥87.2M | CN¥435M |
| Free cash flow | -CN¥135M | -CN¥341M | -CN¥115M | -CN¥398M | -CN¥169M |
| Capital expenditure | CN¥258M | CN¥156M | CN¥160M | CN¥475M | CN¥507M |
| Total debt | CN¥1.23B | CN¥1.07B | CN¥857M | CN¥775M | CN¥912M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301246.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -10.3% | -12.9% | 10th highest of 21 |
| 6-month return | -47.0% | -24.5% | 3rd lowest of 20 |
| Distance from 52-week high | -55.3% | -51.3% | 7th lowest of 21 |
| Revenue growth (TTM) | +45.2% | +10.8% | 2nd highest of 21 |
| Operating margin | 12.3% | 1.5% | 5th highest of 21 |
| EV / Sales | 1.5× | 2.2× | 7th cheapest of 20 |
| ROIC minus cost of capital | +0.2 pp | -4.3 pp | 6th highest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Hubei Hongyuan Pharmaceutical Technology 301246.SZ | China | $639M | -47% | +45% | 12% | 1.5× | n/a | n/a |
| Yueyang Xingchang Petro-Chemical 000819.SZ | China | $636M | -29% | +44% | 1% | 1.0× | n/a | n/a |
| LOTTE Fine Chem 004000.KS | South Korea | $634M | -51% | +18% | 7% | 0.4× | -8.2% | +6.8% |
| Hongbaoli 002165.SZ | China | $645M | -32% | +10% | -19% | 2.0× | n/a | n/a |
| Miracll Chemicals 300848.SZ | China | $632M | -45% | +23% | 1% | 2.8× | n/a | n/a |
| Xilong Scientific 002584.SZ | China | $632M | -11% | +23% | 1% | 0.7× | n/a | n/a |
| Hangzhou Gaoxin Materials Technology 300478.SZ | China | $631M | +11% | -21% | -9% | 12.6× | 30.8% | -0.9% |
| Foosung 093370.KS | South Korea | $648M | -38% | +27% | 8% | 2.1× | n/a | n/a |
| Chori 8014.T | Japan | $629M | -6% | +3% | 4% | 0.2× | -13.4% | +6.7% |
| Allied Supreme 4770.TW | Taiwan | $629M | +12% | -15% | 19% | 3.6× | 3.4% | +12.4% |
| Beijing Shougang LanzaTech Technology 2553.HK | Hong Kong | $653M | n/a | 0% | -45% | 9.8× | n/a | n/a |
| Jiangsu Baichuan High-Tech New Materials 002455.SZ | China | $656M | -42% | +9% | 1% | 1.6× | n/a | n/a |
| Longyan Zhuoyue New Energy 688196.SS | China | $622M | -38% | +2% | 1% | 1.4× | n/a | n/a |
| Waga Energy WAGA.PA | France | $659M | -3% | +7% | -20% | n/a | n/a | n/a |
| Argus (Shanghai) Textile Chemicals 603790.SS | China | $618M | -11% | +21% | 14% | 4.2× | 11.7% | +0.7% |
| Anshan Hifichem 300758.SZ | China | $615M | -22% | +11% | 9% | 3.0× | 15.5% | +8.2% |
| Formosan Union Chemical 1709.TW | Taiwan | $607M | +128% | -3% | 14% | 2.2× | -1.6% | +1.2% |
| Lightwave Logic LWLG | United States | $673M | -73% | +165% | -9,688% | 2,315.8× | n/a | n/a |
| Zanyu Technology 002637.SZ | China | $605M | -34% | -3% | 3% | 0.5× | -0.9% | +11.0% |
| Anhui Estone Materials Technology 688733.SS | China | $676M | -25% | +44% | -5% | 6.9× | n/a | n/a |
| Balaji Amines BALAMINES.NS | India | $604M | +15% | +21% | 19% | 3.5× | n/a | n/a |